How to Use Cerebral Vasodilators and Metabolic Activators
スポンサーリンク
概要
- 論文の詳細を見る
Cerebral vasodilators and metabolic activators (enhancers) for the treatment of cerebrovascular disorders (CVD) have been categorized and introduced into clinical practice according to their pharmacological actions and clinical indications. The main therapeutic goal of these drugs is to relieve residual subjective symptoms and neuropsychological dysfunction, which reduce the quality of life of patients in the chronic stage of stroke. Selection of the most suitable drug for the individual symptoms of each patient is an important therapeutic principle.
- 東海大学の論文
著者
-
Izumi Yoshio
Department Of Neurology Tokai University School Of Medicine
-
Isozumi Kazuo
Department Of Neurology Ashikaga Red Cross Hospital
関連論文
- Effect of Thyrotropin-Releasing Hormone (TRH) on Cerebral Blood Flow in Spinocerebellar Degeneration and Cerebrovascular Disease
- Effect of Sympathetic Stimulation on Cerebral Circulation
- Effect of Sympathetic Nervous System Stimulation on Cerebrovascular CO_2 Responsiveness
- Experimental Models and Treatment Trials for Cerebral Infarction
- How to Use Cerebral Vasodilators and Metabolic Activators
- Modern Japanese medical history and the European influence
- Obesity as a risk factor for cerebrovascular disease